Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

576
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
576
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

560
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
560
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.9K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

728
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
728
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

837
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
837
Inflammation01:38

Inflammation

64.0K
Overview
64.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interplay of Oxidative Stress and Inflammatory Mechanisms in Doxorubicin-induced Cardiomyopathy.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Promising results with stem-cell-derived tissue transplantation in heart failure.

Nature reviews. Cardiology·2026
Same author

The direction of cardiomyocyte growth is orchestrated by microtubule dynamics.

Nature reviews. Cardiology·2026
Same author

Fibrosis-targeted, immunosuppressive dendritic cells mitigate cardiac adverse remodelling.

Nature reviews. Cardiology·2026
Same author

Placebo-controlled evidence for symptomatic benefit of PCI for chronic total occlusion in stable angina.

Nature reviews. Cardiology·2026
Same author

Left atrial appendage closure non-inferior to NOACs in atrial fibrillation.

Nature reviews. Cardiology·2026

Related Experiment Video

Updated: Mar 24, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.9K

Atherosclerosis--do we know enough already to prevent it?

Chandrakala Aluganti Narasimhulu1, Irene Fernandez-Ruiz1, Krithika Selvarajan1

  • 1Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, United States.

Current Opinion in Pharmacology
|March 15, 2016
PubMed
Summary

This review details atherosclerosis development, a complex process involving lipids, lipoproteins, and various cellular events like oxidative stress and inflammation. Understanding each stage may reveal new therapeutic targets for this progressive cardiovascular disease.

More Related Videos

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.9K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.0K

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Pathophysiology

Background:

  • Atherosclerosis is a complex, progressive disease involving lipids and lipoproteins.
  • Numerous interconnected cellular and acellular processes contribute to its development.
  • Key factors include oxidative stress, lipoprotein modification, and inflammatory responses.

Purpose of the Study:

  • To review the characteristics of lipids and lipoproteins.
  • To summarize the multifaceted atherosclerotic process.
  • To identify potential therapeutic targets by understanding disease stages.

Main Methods:

  • Literature review of lipid and lipoprotein characteristics.
  • Synthesis of current knowledge on atherosclerotic mechanisms.
  • Analysis of cellular and acellular processes involved in plaque development.

Main Results:

  • Atherosclerosis involves a continuous interplay of oxidative stress, lipoprotein modifications, macrophage dynamics, inflammation, calcification, and cellular proliferation.
  • The precise roles of many contributing factors remain to be elucidated.
  • Interventions targeting one stage may not affect others.

Conclusions:

  • Understanding the specific events at each stage of atherosclerosis is crucial.
  • Elucidating these mechanisms may reveal novel targets for therapeutic intervention.
  • Future treatments may need to be stage-specific for maximum efficacy.